The 12 closest competitors and alternatives to Kernal Biologics, Inc. among biotech companies — ranked by similarity to what Kernal Biologics, Inc. actually does, not by market-cap band.
Subscribe to see Kernal Biologics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kernal Biologics is an onco-selective mRNA therapeutics company located in Cambridge, Massachusetts, that creates mRNA therapies designed to instruct specific cells on how to make proteins.
Kernal Biologics, Inc. is a biotech company headquartered in United States. Its most recent funding round, Series A, raised $25M in July 2022. Xcout tracks 7 named people at Kernal Biologics, Inc., including Stephen DiPalma (Chief Financial Officer). Xcout recorded 7 job postings from Kernal Biologics, Inc. in the last 90 days.
1 more named person on record for Kernal Biologics, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $25M | 4 named | |
| SEC Form D filing | $20.1M | — | |
| SEC Form D filing | $500,000 | — | |
| SEC Form D filing | $350,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 7 job postings from Kernal Biologics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Kernal Biologics, Inc.'s hiring signals →
Ranked by semantic similarity — how close each company is to Kernal Biologics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
CREATE Medicines is a clinical-stage biotechnology company located in Cambridge, Massachusetts, pioneering in vivo immune programming with RNA.
Similar biotech company
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Biotechnology
HelixNano is a biotechnology research company headquartered in Boston, Massachusetts, focused on developing advanced mRNA platform technologies for therapeutics.
Biotechnology
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Similar biotech company
Senda Biosciences is a biotechnology company focused on harnessing nature to program novel medicines, headquartered in Cambridge, Massachusetts.
Biotechnology
Stipple Bio, Inc. is a private biotechnology company headquartered in Cambridge, Massachusetts, United States, focused on harnessing epitope-level precision in therapeutics.
Biotechnology
Ankyra Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The company develops localized immune-mediated therapies for the treatment of cancer.
Similar biotech company
Flare Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts, focused on pioneering precision therapeutics.
Similar biotech company
Constructive Bio is a biotechnology research company headquartered in Cambridge, United Kingdom, that focuses on designing and manufacturing proteins with non-canonical amino acids for new medicines and materials.
Similar biotech company
Pretzel Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, advancing a new class of medicines that target cellular energetics and mitochondrial function.
Life Sciences
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Biotechnology
Rgenta Therapeutics, Inc. is a biotechnology research company headquartered in Woburn, Massachusetts, that focuses on unlocking the therapeutic potential of disease-relevant RNA targets.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Kernal Biologics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →